Lihuayi Weiyuan Chemical Co., Ltd.

SSE:600955.SS

13.04 (CNY) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 2,308.2672,687.282,373.6042,136.0782,119.1761,737.9391,496.8911,692.8711,903.941,924.8211,992.4521,976.9012,286.3362,582.3382,514.8412,251.1011,520.6441,012.855926.45926.45
Cost of Revenue 2,273.3032,644.3632,360.9782,096.8732,078.5471,628.8741,469.5111,647.2151,760.4981,875.5761,794.6471,562.5461,848.3661,755.2571,616.4381,426.9651,012.702751.141794.682794.682
Gross Profit 34.96442.91812.62639.20540.629109.06527.3845.655143.44249.245197.804414.355437.971827.081898.403824.136507.941261.714131.768131.768
Gross Profit Ratio 0.0150.0160.0050.0180.0190.0630.0180.0270.0750.0260.0990.210.1920.320.3570.3660.3340.2580.1420.142
Reseach & Development Expenses 7.5758.2858.0568.8331.40312.0468.2176.2226.1716.4096.0159.4699.533.8911.0870.9641.8522.28200
General & Administrative Expenses -49.19269.657-24.25832.371-52.30765.03-4.90316.748-30.87355.984-3.00516.664-21.31747.869-6.23613.064-20.98114.30100
Selling & Marketing Expenses -1.503-52.950.7310.8690.560.6740.6780.7920.7420.8420.7680.5990.6020.832-0.5561.7981.7661.07100
SG&A -50.69516.70723.86633.2433.28265.704-4.22517.54-30.13156.826-2.23817.263-20.71448.701-6.79214.862-19.21415.37200
Other Expenses 120.2850-18.8730.22-16.7870.1070.1271.10627.256-21.58424.2735.93845.463-1.49-0.478-0.162-0.2910.71400
Operating Expenses 77.16524.99350.79442.07451.47247.31934.91324.8683.29641.65128.0532.6734.27941.68331.46529.02821.84720.6221.3381.338
Operating Income -42.20117.925-38.168-2.869-10.84268.5420.77234.099149.65521.004203.083405.223425.9781.291862.732788.559466.086219.797131.768131.768
Operating Income Ratio -0.0180.007-0.016-0.001-0.0050.0390.0010.020.0790.0110.1020.2050.1860.3030.3430.350.3070.2170.1420.142
Total Other Income Expenses Net 0.02944.7330.52728.2711.5020.1070.1270.1130.2719.756-0.501-0.2031.906-1.49-0.478-0.162-0.2910.714-1.338-1.338
Income Before Tax -42.17262.65811.62725.7942.16568.6480.89934.211149.92630.76202.581405.02427.807779.801862.254788.397465.794220.511130.43130.43
Income Before Tax Ratio -0.0180.0230.0050.0120.0010.0390.0010.020.0790.0160.1020.2050.1870.3020.3430.350.3060.2180.1410.141
Income Tax Expense -10.8910.295-5.2396.313-10.32212.894-4.8938.12433.268-1.49447.503101.236100.945194.271215.858197.472111.52455.32432.60532.605
Net Income -31.28252.13216.64919.08910.98155.7555.79226.087116.65732.254155.078303.784326.862585.53646.396590.925354.27165.18797.82597.825
Net Income Ratio -0.0140.0190.0070.0090.0050.0320.0040.0150.0610.0170.0780.1540.1430.2270.2570.2630.2330.1630.1060.106
EPS -0.0550.0950.030.0350.020.10.0110.0470.210.0590.280.550.591.061.181.430.640.30.1780.178
EPS Diluted -0.0550.0950.030.0350.020.10.0110.0470.210.0580.280.550.591.061.181.430.640.30.1780.178
EBITDA -19.23368.471188.353132.853121.057184.699114.338143.698258.769133.416306.55509.176491.519874.89963.622882.257560.646242.967233.092233.092
EBITDA Ratio -0.0080.0250.0790.0620.0570.1060.0760.0850.1360.0690.1540.2580.2150.3390.3830.3920.3690.240.2520.252